PDF(480 KB)
Construction of Emergency Prevention and Control System for Public Health Emergencies in China
Zhuoran Wang, Mingsui Li, Huili Jiang, Juntao Yang, Weizhong Yang, Depei Liu
Strategic Study of CAE ›› 2021, Vol. 23 ›› Issue (5) : 18-23.
PDF(480 KB)
PDF(480 KB)
Construction of Emergency Prevention and Control System for Public Health Emergencies in China
Public health emergencies severely affect people’s lives and health, national security, social stability, and economic development. Against the background of coronavirus disease 2019 pandemic, this study analyzes the current status of China’s public health emergency prevention and control system from the aspects of its six major systems: monitoring, early warning, and evaluation; diagnosis and treatment; basic scientific research; personnel training; material, equipment, and industry support; and social mobilization and coordinated action. We conclude that strengthening system construction is a realistic demand of China in the new development stage. China’s public health system still faces challenges regarding institutional positioning, capacity building, hardware investment, and management system. Therefore, we propose that China should establish a national overall coordination and emergency command mechanism, strengthen clinical, science, education, and industrial support capacity, and further promote international cooperation.
public health emergencies / prevention and control system / integration of prevention and treatment / detection and early warning / industrial support
| [1] |
中华人民共和国国务院. 突发公共卫生事件应急条例 [EB/ OL]. （2020-12-26）[2021-08-24]. http://www.gov.cn/zhengce/ 2020-12/26/content_5574586.htm. The State Council of the PRC. Regulations on emergency response to public health emergencies [EB/OL]. （2020-12-26）[2021-08-24]. http://www.gov.cn/zhengce/2020-12/26/content_5574586.htm.
|
| [2] |
黎爱军, 孙亚林. 新型冠状病毒肺炎疫情防控的应急科研攻关 [J]. 解放军医院管理杂志, 2021, 28(3): 272–274. Li A J, Sun Y L. Emergency scientific research for COVID-19 prevention and control [J]. Hospital Administration Journal of Chinese People’s Liberation Army, 2021, 28(3): 272–274.
|
| [3] |
詹思延. 流行病学(第8版) [M]. 北京: 人民卫生出版社, 2017: 191–193. Zhan S Y. Epidemiology (8ed) [M]. Beijing: People’s Medical Publishing House, 2017: 191–193.
|
| [4] |
中华人民共和国国务院 . “健康中国 2030”规划纲要 [EB/ OL]. (2016-10-25)[2021-08-24]. http://www.gov.cn/xinwen/2016-10/25/content_5124174.htm. The State Council of the PRC.“Healthy China 2030” plan outline [EB/OL]. (2016-10-25)[2021-08-24]. http://www.gov.cn/ xinwen/2016-10/25/content_5124174.htm.
|
| [5] |
国家发展和改革委员会, 国家卫生健康委员会, 国家中医药管 理局. 公共卫生防控救治能力建设方案 [EB/OL]. (2020-05-09) [2021-08-24]. http://www.gov.cn/zhengce/zhengceku/2020-05/21/ content_5513538.htm. National Development and Reform Commission, National Health Commission of the PRC, National Administration of Traditional Chinese Medicine. The plan for improving public health prevention, control and treatment capacity [EB/OL]. (2020-05-09) [2021-08-24]. http://www.gov.cn/zhengce/zhengceku/2020-05/21/ content_5513538.htm.
|
| [6] |
邹家凤, 郑海山. 疾控机构实验室能力建设与管理调查报告 [J]. 医学信息(中旬刊), 2010, 5(6): 1338–1339. Zou J F, Zheng H S. An investigation on the capability and adiministration of laboratories in disease control organizations [J]. Medical Information, 2010, 5(6): 1338–1339.
|
| [7] |
杜晶琳, 史烨梁, 徐佳南, 等.江苏省新型冠状病毒核酸检测实验 室能力建设调查 [J].中国卫生资源, 2021, 24(3): 238–242. Du J L, Shi Y L, Xu J N, et al. An Investigation on detection ability construction of Laboratories in nucleic acid detection for novel coronavirus in Jiangsu Province [J]. Chinese Health Resources, 2021, 24(3): 238–242.
|
| [8] |
戚淑叶, 许明哲. 基于世界卫生组织认证分析我国医药行业国 际化的机遇与挑战 [J]. 中国药事, 2021, 35(1): 1–9. Qi S Y, Xu M Z. On Internationalization of Chinese pharmaceutical industries based on the WHO prequalification program: Opportunities and challenges [J]. Chinese Pharmaceutical Affairs, 2021, 35(1): 1–9.
|
| [9] |
李程跃, 武娜娜, 刘鹏程, 等. 我国公共卫生教育存在的主要问 题与对策 [J]. 医学与社会, 2016, 29(4): 86–89. Li C Y, Wu N N, Liu P C, et al. Problems and countermeasures of public health education in China [J]. Medicine and Society, 2016, 29(4): 86–89.
|
| [10] |
李耀华, 李思, 仉琪. 新冠疫情中对《医疗器械应急审批程序》 的思考 [J]. 中国药事, 2020, 34(4): 381–386. Li Y H, Li S, Zhang Q. The reflection of emergency approval procedures in the COVID-19 outbreak [J]. Chinese Pharmaceutical Affairs, 2020, 34(4): 381–386.
|
| [11] |
徐冶琼. 重大疫情防控中中国社会动员: 经验、挑战与启示 [J]. 北京航空航天大学学报(社会科学版), 2020, 33(6): 61–66. Xu Y Q. China social mobilization in the prevention and control of major epidemic diseases: Experience，challenges and inspirations [J]. Journal of Beijing University of Aeronautics and Astronautics (Social Sciences Edition), 2020, 33(6): 61–66.
|
| [12] |
国家卫生健康委员会. 2019年我国卫生健康事业发展统计公 报 [EB/OL]. (2020-06-06)[2021-08-24]. http://www.nhc.gov.cn/ guihuaxxs/s10748/202006/ebfe31f24cc145b198dd730603ec4442. shtml. The State Council of the PRC. The statistical bulletin of China’s health development in 2019 [EB/OL]. (2020-06-06)[2021-08-24]. http://www.nhc.gov.cn/guihuaxxs/s10748/202006/ebfe31f24cc145 b198dd730603ec4442.shtml.
|
| [13] |
中华人民共和国卫生部. 医药卫生中长期人才发展规划 （2011—2020年）[EB/OL]. (2011-04-28)[2021-08-24]. http:// www.nhc.gov.cn/renshi/s3573/201104/ff5e914696cb461f9b8353a 463198f54.shtml. The Ministry of Health of the PRC. Medium and long term talent development plan for medicine and health (2011—2020) [EB/ OL]. (2011-04-28)[2021-08-24]. http://www.nhc.gov.cn/renshi/ s3573/201104/ff5e914696cb461f9b8353a463198f54.shtml.
|
/
| 〈 |
|
〉 |
AI Summary
